Caribou Biosciences, Inc. Common Stock — Institutional Ownership
Which tracked institutions hold CRBU, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
25
Funds holding
$32016965
Total value held
Buying
17 added/new · 4 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | $13755883 | 7815843 | +5672758 | +264.70% |
| 2 | Pfizer Inc | $7879924 | 4690431 | — | Held |
| 3 | State Street Corp | $2873929 | 1632914 | +1209651 | +285.79% |
| 4 | Bank Of America Corp /De/ | $2483287 | 1410958 | +113791 | +8.77% |
| 5 | Northern Trust Corp | $1254819 | 712965 | +495230 | +227.45% |
| 6 | Ubs Group Ag | $910573 | 517371 | +517371 | NEW BUY |
| 7 | Goldman Sachs Group Inc | $568260 | 322875 | -53714 | -14.26% |
| 8 | Invesco Ltd. | $529966 | 301117 | +301117 | NEW BUY |
| 9 | Wells Fargo & Company/Mn | $525035 | 298315 | -5340 | -1.76% |
| 10 | Bank Of New York Mellon Corp | $391706 | 222560 | +210049 | +1678.91% |
| 11 | Morgan Stanley | $213523 | 121320 | -123792 | -50.50% |
| 12 | Citigroup Inc | $107907 | 61311 | -13260 | -17.78% |
| 13 | Barclays Plc | $88549 | 50312 | +23599 | +88.34% |
| 14 | Jpmorgan Chase & Co | $75985 | 42929 | +36840 | +605.03% |
| 15 | Sei Investments Co | $73813 | 41939 | +10931 | +35.25% |
| 16 | Prudential Financial Inc | $60500 | 34375 | +15375 | +80.92% |
| 17 | Us Bancorp \De\ | $60306 | 34265 | — | Held |
| 18 | Ameriprise Financial Inc | $51973 | 29530 | +29530 | NEW BUY |
| 19 | Bank Of Montreal /Can/ | $46640 | 26500 | +5500 | +26.19% |
| 20 | Raymond James Financial Inc | $36140 | 20534 | +4161 | +25.41% |
| 21 | Royal Bank Of Canada | $10000 | 5344 | +2882 | +117.06% |
| 22 | Pnc Financial Services Group, Inc. | $7779 | 4420 | — | Held |
| 23 | Atlantic Union Bankshares Corp | $5632 | 3200 | — | Held |
| 24 | Federated Hermes, Inc. | $4791 | 2722 | +2722 | NEW BUY |
| 25 | Amalgamated Financial Corp. | $45 | 4851 | +4851 | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.